Breckenridge Pharmaceutical
-
USFDA gives nod to Natco’s marketing partner for cancer drug
There are plans to launch 2.5 mg, 5 mg and 7.5 mg strengths of the drug within the next few…
Read More » -
Natco Pharma’s partner gets US FDA nod for cancer treatment drug
In addition, Natco and Breckenridge have settled the patent litigation with Celgene in the US district court Natco Pharma said…
Read More »